Partner 9 - Proteomika

Proteomika is a biomarker discovery and immunodiagnostic-focused company providing the healthcare community with new tools for personalized medicine. Proteomika is aimed at the discovery of novel biomarkers in several types of biological samples. The company’s proteomics department specialises in immunoassay development and technologies.

In addition to CEED3, Proteomika’s expertise in biomarkers discovery, proteomic data interpretation, bioassay design and development has formed an essential role in several other European consortiums.

Proteomika’s main role in CEED3 is the identification of proteins that have the potential to be used as diagnostic and prognostic disease markers or as potential therapeutic targets.

Proteomika PI: Dr Daniel Nagore
Chief Scientific Officer

For more information about Proteomika please click here